Holen Sie sich die Stockscreener-App
72.37
3.51%
-2.63
Handel nachbörslich:
70.64
-1.73
-2.39%
Schlusskurs vom Vortag:
$75.00
Offen:
$74.9
24-Stunden-Volumen:
3.13M
Relative Volume:
1.42
Marktkapitalisierung:
$13.58B
Einnahmen:
$516.85M
Nettoeinkommen (Verlust:
$174.11M
KGV:
83.18
EPS:
0.87
Netto-Cashflow:
$217.38M
1W Leistung:
-6.10%
1M Leistung:
+30.35%
6M Leistung:
+98.65%
1J Leistung:
+149.38%
1-Tages-Spanne:
$71.59
$75.00
1-Wochen-Bereich:
$71.59
$79.97
52-Wochen-Spanne:
$22.96
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Rice Hall James & Associates LLC Sells 133,151 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Why Doximity’s Surging Stock is the Talk of Wall Street - MotoPaddock
Unlocking the Surge: How Doximity Became a Healthcare Powerhouse - Jomfruland.net
Doximity (DOCS) Demonstrated Strong Fundamentals in Q4 - Insider Monkey
DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.’s Directors and Officers for Breach of Fiduciary Duties – DOCS - Business Wire
4,073 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Hardy Reed LLC - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Holdings Lifted by Venturi Wealth Management LLC - MarketBeat
State of New Jersey Common Pension Fund D Sells 6,893 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
9,628 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Sheaff Brock Investment Advisors LLC - MarketBeat
NYSE: DOCS: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Doximity, Inc. - ACCESS Newswire
Doximity, Inc. (NASDAQ:DOCS) Stake Lessened by Baillie Gifford & Co. - MarketBeat
Peering Into Doximity's Recent Short Interest - Benzinga
Doximity, Inc. (DOCS): the Best Performing Healthcare Stock So Far in 2025 - Insider Monkey
Choreo LLC Purchases New Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Stratos Wealth Partners LTD. Buys New Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Why Doximity (DOCS) Went Up On Friday? - MSN
Doximity's SWOT analysis: physician network stock faces growth hurdles - Investing.com India
Doximity's SWOT analysis: physician network stock faces growth hurdles By Investing.com - Investing.com Nigeria
Empowered Funds LLC Makes New $3.01 Million Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Shares Gap DownHere's Why - MarketBeat
Leerink Partners Upgrades Doximity (DOCS) - MSN
Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Entropy Technologies LP - MarketBeat
Doximity, Inc. : Your health comes first -February 15, 2025 at 04:47 pm EST - Marketscreener.com
Doximity CEO Jeffrey Tangney sells $75.7 million in stock - MSN
Jefferies raises Doximity stock price target to $88, maintains Buy - MSN
IMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Doximity director Benjamin Regina M. sells $3.05 million in stock - MSN
Doximity: Rating Downgrade As Near-Term Upside Is Priced In (NYSE:DOCS) - Seeking Alpha
IMPORTANT DEADLINE ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm - ACCESS Newswire
Top 10 Health Information Services Stocks Outpacing The Market In 2025 - Insider Monkey
Doximity, Inc. (DOCS): Among the Health Information Services Stocks Outpacing the Market in 2025 - MSN
Doximity Momentum, Big Money Support Stays Strong - FX Empire
Newbridge Financial Services Group Inc. Acquires Shares of 6,780 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity director Yang Watkin Phoebe L. sells $217,209 in stock By Investing.com - Investing.com Nigeria
Summit Trail Advisors LLC Lowers Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity director Yang Watkin Phoebe L. sells $217,209 in stock - MSN
Why Doximity, Inc. (DOCS) Soared Last Week? - MSN
Doximity CEO Jeffrey Tangney sells $75.7 million in stock By Investing.com - Investing.com Australia
Doximity CFO Bryson Anna sells $7.22 million in stock - MSN
Doximity director Benjamin Regina M. sells $3.05 million in stock By Investing.com - Investing.com South Africa
Why Doximity Stock Skyrocketed Higher Today - AOL
Doximity (NASDAQ:DOCS) Stock Price Up 6.7% After Analyst Upgrade - MarketBeat
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.99%
2.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):